Cardiovascular Diabetology | Most Viewed

Submit a manuscript Register Contact us Follow
BioMed Central Support

Explore journal

Advertisement

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 1452 Accesses	Original investigation Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study Antoinette V Buys, Mia-Jean Van Rooy, Prashilla Soma, Dirk Van Papendorp, Boguslaw Lipinski, Etheresia Pretorius Cardiovascular Diabetology 2013, 12:25 (28 January 2013) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	2. 1142 Accesses	Original investigation Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report Hirofumi Suzuki, Masaya Sakamoto, Takeshi Hayashi, Hiroyuki Iuchi, Kennosuke Ohashi, Tsuyoshi Isaka, Noriko Sakamoto, Yosuke Kayama, Katsuyoshi Tojo, Michihiro Yoshimura, Kazunori Utsunomiya Cardiovascular Diabetology 2013, 12:71 (2 May 2013) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	3. 982 Accesses	Original investigation Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme Odd Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, Hans-Juergen Woerle Cardiovascular Diabetology 2012, 11:3 (10 January 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	4. 971 Accesses	Review The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes Diethelm Tschöpe, Markolf Hanefeld, Juris J Meier, Anselm K Gitt, Martin Halle, Peter Bramlage, Petra-Maria Schumm-Draeger Cardiovascular Diabetology 2013, 12:62 (10 April 2013) Abstract \| Provisional PDF \| PubMed
	5. 962 Accesses	Original investigation Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study Tommy Jönsson, Yvonne Granfeldt, Bo Ahrén, Ulla-Carin Branell, Gunvor Pålsson, Anita Hansson, Margareta Söderström, Staffan Lindeberg Cardiovascular Diabetology 2009, 8:35 (16 July 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	6. 884 Accesses	Original investigation Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes Guoxin Tong, Ningfu Wang, Jianhang Leng, Xiaoshan Tong, Yun Shen, Jianmin Yang, Xianhua Ye, Liang Zhou, Yujie Zhou Cardiovascular Diabetology 2013, 12:67 (17 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	7. 804 Accesses	Original investigation Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study) Masaya Sakamoto, Rimei Nishimura, Taiga Irako, Daisuke Tsujino, Kiyotaka Ando, Kazunori Utsunomiya Cardiovascular Diabetology 2012, 11:92 (6 August 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	8. 800 Accesses	Review Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice Jeanette Johansen, Alex K Harris, David J Rychly, Adviye Ergul Cardiovascular Diabetology 2005, 4:5 (29 April 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	9. 739 Accesses	Review How hyperglycemia promotes atherosclerosis: molecular mechanisms Doron Aronson, Elliot J Rayfield Cardiovascular Diabetology 2002, 1:1 (8 April 2002) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	10. 734 Accesses	Original investigation The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study Arne Ring, Tobias Brand, Sreeraj Macha, Kerstin Breithaupt-Groegler, Gudrun Simons, Beate Walter, Hans J Woerle, Uli C Broedl Cardiovascular Diabetology 2013, 12:70 (24 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	11. 720 Accesses	Original investigation Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report Miao-yan Zheng, Ju-hong Yang, Chun-yan Shan, Hong-tao Zhou, Yan-guang Xu, Ying Wang, Hui-zhu Ren, Bao-cheng Chang, Li-ming Chen Cardiovascular Diabetology 2013, 12:73 (4 May 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	12. 712 Accesses	Original investigation Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials Maximilian von Eynatten, Yan Gong, Angela Emser, Hans-Juergen Woerle Cardiovascular Diabetology 2013, 12:60 (9 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	13. 671 Accesses	Original investigation TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction Jing Sun, Yunfei Pu, Peijian Wang, Sijiao Chen, Yu Zhao, Chan Liu, Qianhui Shang, Zhiming Zhu, Daoyan Liu Cardiovascular Diabetology 2013, 12:69 (22 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	14. 640 Accesses	Original investigation Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS) Eyal Leibovitz, Shmuel Gottlieb, Ilan Goldenberg, Natalie Gevrielov-Yusim, Shlomi Matetzky, Dov Gavish Cardiovascular Diabetology 2013, 12:53 (28 March 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	15. 619 Accesses	Original investigation Effects of sitagliptin beyond glycemic control: focus on quality of life Yoshiko Sakamoto, Jun-ichi Oyama, Hideo Ikeda, Shigetaka Kuroki, Shigeki Gondo, Taketo Iwamoto, Yasufumi Uchida, Kazuhisa Kodama, Atsushi Hiwatashi, Mitsuhiro Shimomura, Isao Taguchi, Teruo Inoue, Koichi Node, S-DOG [Saga Challenge Anti-Diabetes Observational Study for Sitagliptin (S-DOG)] investigators Cardiovascular Diabetology 2013, 12:35 (21 February 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	16. 602 Accesses	Original investigation Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis Samuel S Engel, Gregory T Golm, Deborah Shapiro, Michael J Davies, Keith D Kaufman, Barry J Goldstein Cardiovascular Diabetology 2013, 12:3 (3 January 2013) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	17. 572 Accesses	Review What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment? Samir G Mallat Cardiovascular Diabetology 2012, 11:32 (10 April 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	18. 569 Accesses	Review Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data Michael E Cobble, Robert Frederich Cardiovascular Diabetology 2012, 11:6 (16 January 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	19. 553 Accesses	Original investigation The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats Jianxin Lu, Jingzhang Ji, Howard Meng, David Wang, Bo Jiang, Lixin Liu, Edward Randell, Khosrow Adeli, Qing H Meng Cardiovascular Diabetology 2013, 12:58 (5 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	20. 525 Accesses	Original investigation Protein Kinase C inhibition ameliorates functional endothelial insulin resistance and Vascular Smooth Muscle Cell hypersensitivity to insulin in diabetic hypertensive rats Xiao Lu, James S Bean, Ghassan S Kassab, Mark D Rekhter Cardiovascular Diabetology 2011, 10:48 (2 June 2011) Abstract \| Full text \| PDF \| PubMed
	21. 509 Accesses	Review Endothelial dysfunction: a comprehensive appraisal Ricardo J Esper, Roberto A Nordaby, Jorge O Vilariño, Antonio Paragano, José L Cacharrón, Rogelio A Machado Cardiovascular Diabetology 2006, 5:4 (23 February 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	22. 499 Accesses	Original investigation Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus – results from an exploratory study Christine Berndt-Zipfel, Georg Michelson, Markus Dworak, Michael Mitry, Andrea Löffler, Andreas Pfützner, Thomas Forst Cardiovascular Diabetology 2013, 12:59 (8 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	23. 482 Accesses	Original investigation Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients Anna Cabré, Pilar Valdovinos, Iolanda Lázaro, Gil Bonet, Alfredo Bardají, Lluís Masana Cardiovascular Diabetology 2013, 12:72 (4 May 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	24. 465 Accesses	Original investigation Impact of post-challenge hyperglycemia on clinical outcomes in japanese patients with stable angina undergoing percutaneous coronary intervention Shoichi Kuramitsu, Hiroyoshi Yokoi, Takenori Domei, Akihiro Nomura, Hirotoshi Watanabe, Kyohei Yamaji, Yoshimitsu Soga, Takeshi Arita, Katsuhiro Kondo, Shinichi Shirai, Kenji Ando, Koyu Sakai, Masashi Iwabuchi, Hedeyuki Nosaka, Masakiyo Nobuyoshi Cardiovascular Diabetology 2013, 12:74 (7 May 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed
	25. 449 Accesses	Original investigation The adaptability of red blood cells Etheresia Pretorius Cardiovascular Diabetology 2013, 12:63 (11 April 2013) Abstract \| Full text \| PDF \| ePUB \| PubMed